These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18291724)

  • 1. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.
    Rüegg S; Naegelin Y; Hardmeier M; Winkler DT; Marsch S; Fuhr P
    Epilepsy Behav; 2008 Apr; 12(3):477-80. PubMed ID: 18291724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S; Reuber M; Maraite N
    Gerontology; 2009; 55(1):27-31. PubMed ID: 18953167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
    Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S; Grumbt M; Müller M; Schulze A
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
    Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
    Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of success in the use of oral levetiracetam in status epilepticus.
    Rossetti AO; Bromfield EB
    Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O; Chang E; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.
    Fattouch J; Di Bonaventura C; Casciato S; Bonini F; Petrucci S; Lapenta L; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2010 Jun; 121(6):418-21. PubMed ID: 20578996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
    Gibbs JE; Walker MC; Cock HR
    Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and dosing experience of intravenous levetiracetam in children and infants.
    Michaelides C; Thibert RL; Shapiro MJ; Kinirons P; John T; Manchharam D; Thiele EA
    Epilepsy Res; 2008 Oct; 81(2-3):143-7. PubMed ID: 18571898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.